NCT02465736 Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02435602 The Role of Chromoendoscopy in the Early Detection of Esophageal Cancer in Patients With Prior Head and Neck Cancers Status COMPLETED Phase NA
NCT02399306 Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma Status COMPLETED Phase PHASE3
NCT02384811 Phase II Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT02350517 Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer Status COMPLETED Phase PHASE2
NCT02325986 Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer Status UNKNOWN Phase PHASE2
NCT02272699 Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma Status WITHDRAWN Phase PHASE2/PHASE3
NCT02047305 Radiofrequency Ablation for Patients With Esophageal Squamous Cell Neoplasia Status COMPLETED Phase NA
NCT01973725 Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional Chemotherapy Status COMPLETED Phase PHASE2
NCT01854749 S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study Status COMPLETED Phase PHASE2
NCT01831531 Study of S-1 in Combination With Radiotherapy in Esophageal Cancer Status COMPLETED Phase PHASE2
NCT01822613 Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC) Status COMPLETED Phase PHASE1
NCT01688908 Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC) Status ACTIVE_NOT_RECRUITING Phase NA
NCT01608022 A Phase II Trial of PF-00299804 in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus Status COMPLETED Phase PHASE2